The best place for the Latest Cardiac and Vascular News
Stent coated with Viagra may help prevent blood clots By AMERICAN HEART ASSOCIATION NEWS Coating heart stents with the erectile dysfunction drug Viagra, known by the generic name sildenafil, could one day reduce blood clots and re-narrowing of arteries, according to new research. Stents prop open heart arteries to help […]
DUBLIN – July 10, 2017 – Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery. With hemodynamic […]
CALGARY, July 10, 2017 /PRNewswire/ – Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announced that the first patient has been randomized in Taiwan in the Phase 3 BETonMACE clinical trial with lead drug apabetalone intended for high-risk patients with cardiovascular disease (“CVD”) and type 2 diabetes mellitus (“DM”). On July 8, 2015, Resverlogix and […]
Medtronic will add Onyx to the Resolute stents available in Japan (Integrity has been selling there since 2012). Resolute Onyx drug-eluting stent launches in Japan JULY 7, 2017 BY SARAH FAULKNER Medtronic (NYSE:MDT) said this week that it’s Resolute Onyx drug-eluting stent will launch in Japan on July 10th. The drug-eluting stent has […]
Creavo Medical Technologies Press Release by Victoria John Creavo Medical Technologies, the UK-based med-tech company, has announced that it has raised a further £13.4m ($17m) in equity funding. The round was oversubscribed and exceeded Creavo’s funding target, reflecting strong investor support and endorsement of Creavo’s strategy and team. Led by IP […]
NEWS PROVIDED BY LifeTech Scientific Corporation 03 Jul, 2017, 11:56 BST FRANKFURT, Germany, July 3, 2017 /PRNewswire/ — On June 30, at the Congenital and Structural Intervention Congress (CSI) 2017 in Frankfurt, LifeTech Scientific Corporation (Stock Code: 1302.HK) announced the launch of a 3-year global post-market surveillance (PMS) study for the LAmbreTM Left Atrial Appendage (LAA) Closure […]
WASHINGTON–(BUSINESS WIRE)–GE Healthcare and HeartFlow, Inc. announced today at SCCT2017, the annual scientific meeting of the Society of Cardiovascular Computed Tomography, that they have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow FFRct, a proprietary technology that helps clinicians diagnose and treat […]
Press Release With worldwide cardiovascular deaths at an all-time high, European scientists have developed a new handheld scanner that can read your heart’s vital signs like a supermarket barcode reader can scan items at the checkout, allowing a GP to diagnose even preclinical patients for the early onset of a […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that the American Medical Association (AMA) has issued a set of new Category III Current Procedural Terminology (CPT®) codes for HeartFlow® FFRct, a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). The CPT code application was submitted […]
IRVINE, Calif., July 5, 2017/PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received U.S. Food and Drug Administration (FDA) approval for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves. […]
